In conclusion, Our finding confirmed that lncRNA DLEU2 as a novel oncogenic in NSCLC, which provide a potential novel diagnostic and therapeutic target for NSCLC. This evidence concerns the gene DLEU2 and non-small cell lung carcinoma.